MERIT MEDICAL SYSTEMS INC
For the period ended Jun 30, 2026. Filed Jul 30, 2026.
View on SEC.govAbout this filing
A company's report for each of its first three quarters. The financial statements are not audited. It shows how the business has moved since the last annual report, and what management says changed.
Jun 30, 2026 · Filed Jul 30, 2026
MMSI$87.81-0.7%Stored close · as of Nov 10, 2026
Extracted filing text, with the paragraph anchors used by the comparison.
See the whole filing, with its images and exhibitsContents
Consolidated Statements of Income
(In thousands, except per share amounts - unaudited)
| | | | | | | | | | | | | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| · · Three Months Ended · · Six Months Ended | ||||||||||||
| · · June 30, · · June 30, | ||||||||||||
| · · 2026 · · 2025 · · 2026 · · 2025 | ||||||||||||
| Net sales | | $418,843 | | $382,462 | | $800,720 | | $737,813 | ||||
| Cost of sales | | 203,677 | | 197,975 | | 400,757 | | 381,306 | ||||
| Gross profit | | 215,166 | | 184,487 | | 399,963 | | 356,507 | ||||
| | | | | | | | | | | | | |
| Operating expenses: | | | | | | | | | ||||
| Selling, general and administrative | | 129,229 | | 113,097 | | 247,439 | | 220,583 | ||||
| Research and development | | 25,389 | | 24,367 | | 47,998 | | 46,845 | ||||
| Contingent consideration expense (benefit) | | 145 | | 143 | | (34) | | 1,166 | ||||
| Total operating expenses | | 154,763 | | 137,607 | | 295,403 | | 268,594 | ||||
| | | | | | | | | | | | | |
| Income from operations | | 60,403 | | 46,880 | | 104,560 | | 87,913 | ||||
| | | | | | | | | | | | | |
| Other income (expense): | | | | | | | | | ||||
| Interest income | | 3,752 | | 3,761 | | 7,652 | | 7,551 | ||||
| Interest expense | | (12,118) | | (6,775) | | (18,644) | | (13,343) | ||||
| Other (expense) income — net | | (723) | | (487) | | 11,292 | | (784) | ||||
| Total other (expense) income — net | | (9,089) | | (3,501) | | 300 | | (6,576) | ||||
| | | | | | | | | | | | | |
| Income before income taxes | | 51,314 | | 43,379 | | 104,860 | | 81,337 | ||||
| | | | | | | | | | | | | |
| Income tax expense | | 12,511 | | 10,798 | | 25,062 | | 18,609 | ||||
| | | | | | | | | | | | | |
| Net income | | $38,803 | | $32,581 | | $79,798 | | $62,728 | ||||
| | | | | | | | | | | | | |
| Earnings per common share | | | | | | | | | ||||
| Basic | | $0.65 | | $0.55 | | $1.34 | | $1.06 | ||||
| Diluted | | $0.65 | | $0.54 | | $1.33 | | $1.03 | ||||
| | | | | | | | | | | | | |
| Weighted average shares outstanding | | | | | | | | | ||||
| Basic | | 59,679 | | 59,140 | | 59,595 | | 59,019 | ||||
| Diluted | | 60,006 | | 60,611 | | 60,010 | | 60,945 | ||||
See condensed notes to consolidated financial statements.
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.